NO991161D0 - TNF-<beta>-lignende protein for behandling av prostatakreft, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder - Google Patents
TNF-<beta>-lignende protein for behandling av prostatakreft, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoderInfo
- Publication number
- NO991161D0 NO991161D0 NO991161A NO991161A NO991161D0 NO 991161 D0 NO991161 D0 NO 991161D0 NO 991161 A NO991161 A NO 991161A NO 991161 A NO991161 A NO 991161A NO 991161 D0 NO991161 D0 NO 991161D0
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- beta
- protein
- treatment
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2592396P | 1996-09-11 | 1996-09-11 | |
PCT/US1997/016191 WO1998011224A1 (en) | 1996-09-11 | 1997-09-11 | Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
Publications (3)
Publication Number | Publication Date |
---|---|
NO991161D0 true NO991161D0 (no) | 1999-03-10 |
NO991161L NO991161L (no) | 1999-05-07 |
NO324815B1 NO324815B1 (no) | 2007-12-10 |
Family
ID=21828810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19991161A NO324815B1 (no) | 1996-09-11 | 1999-03-10 | Anvendelse av et TNF-beta-lignende protein, eller et DNA- eller RNA molekyl som koder for det samme, for fremstilling av et preparat for behandling av androgen-uavhengig prostatacancer |
Country Status (12)
Country | Link |
---|---|
US (1) | US6107476A (no) |
EP (1) | EP0950105A1 (no) |
JP (1) | JP2001500732A (no) |
KR (1) | KR20000038040A (no) |
CN (1) | CN1233289A (no) |
AU (1) | AU735776B2 (no) |
BR (1) | BR9711763A (no) |
CA (1) | CA2265444C (no) |
IL (2) | IL128872A0 (no) |
NO (1) | NO324815B1 (no) |
NZ (1) | NZ334592A (no) |
WO (1) | WO1998011224A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6521227B1 (en) | 1999-11-18 | 2003-02-18 | Peter L. Hudson | Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides |
US5994102A (en) * | 1994-12-15 | 1999-11-30 | Human Genome Sciences, Inc. | Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides |
US6524802B1 (en) * | 1996-03-29 | 2003-02-25 | The Johns Hopkins University School Of Medicine | Methods of detecting growth differentiation factor-14 |
US6465181B2 (en) * | 1999-03-25 | 2002-10-15 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
EP1179067B1 (en) * | 1999-05-17 | 2006-12-13 | BIOPHARM Gesellschaft zur biotechnologischen Entwicklung und zum Vertrieb von Pharmaka mbH | Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily |
US7141661B2 (en) | 2000-09-08 | 2006-11-28 | The United States Of America As Represented By The Department Of Health And Human Services | Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
US20070154889A1 (en) * | 2004-06-25 | 2007-07-05 | Veridex, Llc | Methods and reagents for the detection of melanoma |
US20070237713A1 (en) * | 2006-04-04 | 2007-10-11 | Fan Rong A | PCan065 Antibody Compositions and Methods of Use |
US9550819B2 (en) | 2012-03-27 | 2017-01-24 | Ngm Biopharmaceuticals, Inc. | Compositions and methods of use for treating metabolic disorders |
US9161966B2 (en) | 2013-01-30 | 2015-10-20 | Ngm Biopharmaceuticals, Inc. | GDF15 mutein polypeptides |
JP6272907B2 (ja) | 2013-01-30 | 2018-01-31 | エヌジーエム バイオファーマシューティカルズ インコーポレイテッド | 代謝障害の処置における組成物及び使用方法 |
US10588980B2 (en) | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
JP6704358B2 (ja) | 2014-07-30 | 2020-06-03 | エヌジーエム バイオファーマシューティカルズ インコーポレイテッド | 代謝障害を治療するための組成物および使用方法 |
US9920118B2 (en) | 2014-10-31 | 2018-03-20 | Ngm Biopharmaceuticals, Inc. | Compositions and methods of use for treating metabolic disorders |
JP7021099B2 (ja) | 2016-03-31 | 2022-02-18 | エヌジーエム バイオファーマシューティカルス,インコーポレーテッド | 結合タンパク質及びその使用方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
CA1340740C (en) * | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
JPH07250688A (ja) * | 1994-01-28 | 1995-10-03 | Sagami Chem Res Center | TGF−βスーパーファミリー蛋白質をコードするヒト新規cDNA |
JPH07258293A (ja) * | 1994-03-23 | 1995-10-09 | Asahi Chem Ind Co Ltd | 新規な蛋白質ならびにその製造方法 |
AU1830195A (en) * | 1994-12-15 | 1996-07-03 | Human Genome Sciences, Inc. | Prostatic growth factor |
ATE423788T1 (de) * | 1995-06-22 | 2009-03-15 | St Vincents Hosp Sydney | Neues tgf-beta-ahnliches cytokin |
AU711368B2 (en) * | 1995-06-22 | 1999-10-14 | St Vincent's Hospital Sydney Limited | Novel TGF-beta like cytokine |
US6524802B1 (en) * | 1996-03-29 | 2003-02-25 | The Johns Hopkins University School Of Medicine | Methods of detecting growth differentiation factor-14 |
-
1997
- 1997-09-11 JP JP10513906A patent/JP2001500732A/ja active Pending
- 1997-09-11 NZ NZ334592A patent/NZ334592A/xx not_active IP Right Cessation
- 1997-09-11 WO PCT/US1997/016191 patent/WO1998011224A1/en not_active Application Discontinuation
- 1997-09-11 AU AU43442/97A patent/AU735776B2/en not_active Expired
- 1997-09-11 IL IL12887297A patent/IL128872A0/xx unknown
- 1997-09-11 KR KR1019990701981A patent/KR20000038040A/ko not_active Application Discontinuation
- 1997-09-11 US US08/927,433 patent/US6107476A/en not_active Expired - Lifetime
- 1997-09-11 CN CN97197712A patent/CN1233289A/zh active Pending
- 1997-09-11 EP EP97941557A patent/EP0950105A1/en not_active Withdrawn
- 1997-09-11 BR BR9711763A patent/BR9711763A/pt not_active Application Discontinuation
- 1997-09-11 CA CA002265444A patent/CA2265444C/en not_active Expired - Lifetime
-
1999
- 1999-03-08 IL IL128872A patent/IL128872A/en not_active IP Right Cessation
- 1999-03-10 NO NO19991161A patent/NO324815B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2265444A1 (en) | 1998-03-19 |
CA2265444C (en) | 2008-11-18 |
NO991161L (no) | 1999-05-07 |
NO324815B1 (no) | 2007-12-10 |
KR20000038040A (ko) | 2000-07-05 |
NZ334592A (en) | 2000-10-27 |
CN1233289A (zh) | 1999-10-27 |
AU4344297A (en) | 1998-04-02 |
BR9711763A (pt) | 1999-08-24 |
WO1998011224A1 (en) | 1998-03-19 |
JP2001500732A (ja) | 2001-01-23 |
IL128872A (en) | 2009-08-03 |
IL128872A0 (en) | 2000-01-31 |
US6107476A (en) | 2000-08-22 |
AU735776B2 (en) | 2001-07-12 |
EP0950105A1 (en) | 1999-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991161L (no) | TNF-<beta>-lignende protein for behandling av prostatacancer, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder | |
NO986089D0 (no) | Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o | |
DE69731611D1 (de) | Eine Zusammensetzung enthaltend eine Detergenz und einen ein Tumorsuppressorgen kodierenden, adenoviralen Vektor | |
HUP9901321A3 (en) | Methods and compositions for determining the sequence of nucleic acid molecules | |
NO326660B1 (no) | Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene | |
BR9808881A (pt) | Compostos para imunoterapia de câncer de próstata e métodos para seu uso | |
WO2001072962A3 (en) | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
AU4986700A (en) | Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof | |
IL189132A0 (en) | Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer | |
EE200100717A (et) | Indasooliühendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ja meetodid nende kasutamiseks | |
FI973467A (fi) | DNA-molekyylejä, valmistus ja käyttö geeniterapiassa | |
BR0009505A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
HK1030144A1 (en) | Method for treatment of liver tumours and pharmaceutical compositions for use therein. | |
NO20015828L (no) | Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater | |
NO20015516L (no) | Preparater og anvendelser av ET743 for behandling av kreft | |
ZA200007211B (en) | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis. | |
NO986177L (no) | FremgangsmÕte for fremstilling av terapeutisk DNA | |
DK1117661T3 (da) | Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse | |
HUP0302913A3 (en) | Methods of inducing cancer cell death and tumor regression and preparation of pharmaceutical compositions suitable for treating the same | |
DE60037978D1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
WO1999002704A3 (en) | Dual specifically phosphatase and methods of use | |
EE200000333A (et) | Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod | |
WO2000078795A3 (en) | Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1) | |
DE69916488D1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
EP0910669A4 (en) | ISOLATED NUCLEOTIDE MOLECULES BELONGING TO THE MAGE-B FAMILY, AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |